analytics_image
Peritoneal Dialysis Market Trends, Growth & Innovations (2025–2035)\
Vantage Market Research
Vantage Market Research

Reports - Peritoneal Dialysis Market

iconHealthcare

Peritoneal Dialysis Market

Peritoneal Dialysis Market Trends, Growth & Innovations (2025–2035) by Treatment Type (Continuous Ambulatory Peritoneal Dialysis (CAPD), Automated Peritoneal Dialysis (APD)) by Product (Peritoneal Dialysis Solution, Peritoneal dialysis devices, Peritoneal dialysis sets, Peritoneal dialysis catheters, Other peritoneal dialysis products) by End User (Home-Based Dialysis, Dialysis centers & hospital-based dialysis) by Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa

ppt icon
pdf icon
xlsx icon
power bi icon
immediate delivery icon

Industry Leaders Trust Us For Actionable Intelligence

Revenue Insights

Market Size in 2024

USD 9.56 Billion

Market Size By 2035

USD 16.91 Billion

CAGR (2025 - 2035)

5.4%

Largest Region

Asia Pacific

Fastest Region

North America

Base Year

2024

Historic Data

2021 - 2023

Forecast Period

2025 - 2035

Segments Covered

By Treatment Type, By Product, By End User, By Region

Report Coverage

The final deliverable will encompass both quantitative and qualitative data, providing a comprehensive analysis of the market. The scope is customizable.

Overview

The global Peritoneal Dialysis Market is valued at USD 9.56 Billion in 2024 and is projected to reach a value of USD 16.91 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of 5.4% between 2025 and 2035. The market is driven by increasing prevalence of chronic kidney diseases (CKD) and end-stage renal disease (ESRD) globally.

Key Highlights

  • ​Peritoneal dialysis is a medical procedure used to treat patients with kidney failure, where the peritoneum (a membrane lining the abdominal cavity) is used to filter and remove waste products, excess fluids, and toxins from the blood
  • Based on the Treatment Type, the Continuous Ambulatory Peritoneal Dialysis (CAPD) accounted for significant market share of 59.2% in 2024
  • In 2024, by Product, Peritoneal dialysis devices dominated the market with significant market share of 30.1%
  • Home-Based Dialysis dominated the market with market share of 48.2% in 2024
  • Asia Pacific dominated the market with 50.5% market share in 2024

Peritoneal Dialysis Market Size, 2024 To 2035 (USD Billion)

Treatment Type Overview

​The Treatment Type segment is divided into Continuous Ambulatory Peritoneal Dialysis (CAPD) and Automated Peritoneal Dialysis (APD). The Continuous Ambulatory Peritoneal Dialysis (CAPD) segment held the dominant share in 2024, accounting for significant market share of 59.2%.

Continuous Ambulatory Peritoneal Dialysis (CAPD) segment’s growth is driven by the rising global patient population. Moreover, the widespread availability of continuous ambulatory peritoneal dialysis (CAPD) machines from leading and emerging vendors is fueling the segment’s market expansion. CAPD is a widely used method for renal replacement therapy in end-stage renal failure (ESRF). Its primary advantages include being cost-effective, quick, and easy to use, not requiring a highly skilled operator, and eliminating the need for anticoagulation.

Product Overview

The Product segment is divided into Peritoneal Dialysis Solution, Peritoneal dialysis devices, Peritoneal dialysis sets, Peritoneal dialysis catheters, Other peritoneal dialysis products. In 2024, the Peritoneal dialysis devices segment held largest share of 30.1% in the Peritoneal Dialysis market.

The peritoneal dialysis devices segment leads the market in 2024, driven by increasing demand for advanced and user-friendly dialysis equipment, particularly automated peritoneal dialysis (APD) devices that enhance patient convenience and improve treatment outcomes. Technological innovations in devices, coupled with the growing adoption of home-based dialysis solutions, have propelled the segment’s dominance in the market.

Regional Overview

In 2024, the Asia Pacific captured 48.2% of the revenue share.

Asia Pacific Peritoneal Dialysis market is driven by a high prevalence of hypertension and growing awareness campaigns about peritoneal dialysis. The regions market growth is also supported by the presence of significant unmet healthcare needs. high prevalence of chronic kidney diseases, including those exacerbated by hypertension and diabetes. Growing access to treatment alternatives and raising awareness of the advantages of peritoneal dialysis are also contributing to the rise, which is being driven by the regions major unmet healthcare demands. The Asia Pacific market is also supported by the governments ongoing initiatives to improve patient access to dialysis treatments and the standard of healthcare facilities. Leading manufacturers are introducing cutting-edge peritoneal dialysis technologies and creative product offers to the region.

North America region is anticipated to grow at the highest CAGR during the forecast period, driven by increasing demand for advanced peritoneal dialysis technologies. Government programs, easier access to goods and services, and the construction of modern medical facilities all contribute to the expansion of market. Leading manufacturers' cutting-edge product launches, strategic mergers & acquisitions, and proactive industry player actions also drives the market in the region. The growing number people living in North America with chronic renal and kidney illnesses is another factor driving market growth.

Based on the provided market data, Vantage Market Research offers customizations in the reports to meet the specific needs of clients.

  • Rising Adoption of Home-Based Dialysis: There is increasing demand for home-based peritoneal dialysis due to its convenience, cost-effectiveness, and flexibility for patients compared to in-center hemodialysis
  • Technological Advancements: Innovations such as automated peritoneal dialysis (APD) machines, wearable dialysis devices, and improvements in dialysis fluids are enhancing treatment efficiency and patient comfort
  • Growing Prevalence of Chronic Kidney Disease (CKD): The rising incidence of CKD, driven by factors such as diabetes and hypertension, is significantly boosting the demand for peritoneal dialysis globally
  • Shift Towards Minimally Invasive Treatments: As peritoneal dialysis is less invasive than traditional hemodialysis, patient preference is shifting toward this option, which requires fewer hospital visits and offers greater independence

Track market trends LIVE & outsmart rivals with our Premium Data Intel Tool: Vantage Point

Market Dynamics

Rising Healthcare Expenditure drives the market

Growth in the market is anticipated due to the growing number of people experiencing renal illnesses, such as kidney failure caused by trauma, diabetes, cancer, and age. The sector is growing because of the many advantages of peritoneal dialysis, which include less expensive than hemodialysis, decreased dietary restrictions, increased mobility, ease of use, and needle-free therapy. Furthermore, the market is further driven by improvements in healthcare infrastructure, the rising popularity of home-based dialysis, and the growing demand for reasonably priced medical equipment.

Lack of Skilled Professionals

Stringent government regulations for approving peritoneal dialysis devices are slowing market growth. Furthermore, a rise in the incidence of technical issues and complications such infections, hernias, and catheter obstructions is anticipated to impede the market. Further limiting the markets growth are the shortage of skilled workers and the limited adoption of peritoneal dialysis cyclers, especially among senior populations.

Rising Number of ESRD Patients Globally

Government initiatives, technological advancements, and awareness programs for chronic kidney disease (CKD) are key factors driving market growth. Health practitioners are increasingly favoring peritoneal dialysis over hemodialysis due to its cost-effectiveness, fewer symptom fluctuations, and greater patient mobility. The market is expanding due to the rising number of people suffering from renal failure as well as the introduction of new products such artificial kidneys and low-maintenance dialysis equipment. In addition, chronic conditions like diabetes and high blood pressure, as well as a lack of kidneys available for transplantation because of stringent rules, are anticipated to propel market expansion in the upcoming years.

Competitive Landscape

The Peritoneal Dialysis market is characterized by the presence of several key players, including Baxter International, Fresenius Medical Care, Medtronic, and B. Braun Melsungen AG, who dominate the market with advanced products and established distribution networks. Additionally, emerging players are introducing new technologies and solutions to improve patient outcomes, further intensifying competition. Strategic collaborations, mergers, acquisitions, and continuous R&D investments are also shaping the competitive dynamics of the market.

The key players in the global Peritoneal Dialysis market include - Medtronic Plc among others.

Recent Market Developments

  • In 2022, Dialyss Pte Ltd was acquired by Nextkidney BV, strengthening its technological capabilities in home hemodialysis

The global Peritoneal Dialysis market can be categorized as Treatment Type, Product, End User and Region.

Market Segmentation

ParameterDetails
Segment Covered

By Treatment Type

  • Continuous Ambulatory Peritoneal Dialysis (CAPD) (59.2%)
  • Automated Peritoneal Dialysis (APD)

By Product

  • Peritoneal Dialysis Solution
  • Peritoneal dialysis devices (30.1%)
  • Peritoneal dialysis sets
  • Peritoneal dialysis catheters
  • Other peritoneal dialysis products

By End User

  • Home-Based Dialysis (60.3%)
  • Dialysis centers & hospital-based dialysis

By Region

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, U.K., Italy, Spain, Nordic Countries, Benelux Union, Rest of Europe)
  • Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, South-East Asia, Rest of Asia Pacific) (48.2%)
  • Latin America (Brazil, Argentina, Rest of Latin America)
  • Middle East and Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of MEA)
Companies Covered
  • Medtronic Plc
  • Terumo Corporation
  • Newsol Technologies Inc
  • Renax Biomedical Tech. Co. Ltd
  • Cook Medical Inc
  • Utah Medical Products Inc
  • Fresenius Medical Care AG & Co. KGaA
  • Poly Medicure Ltd
  • Medionics International Inc
  • Baxter International Inc.
Customization ScopeEnjoy complimentary report customization—equivalent to up to 8 analyst working days—with your purchase. Customizations may include additions or modifications to country, regional, or segment-level data.
Pricing and purchase optionsAccess flexible purchase options tailored to your specific research requirements. Explore purchase options

Report coverage & Deliverables

Our PDF Reports And Online Dashboard
Will Help You Stay Ahead In The Market.

    Key features include:

  • Check
    Competitive benchmarking
  • Check
    Historical data and future forecasts
  • Check
    Company-wise revenue breakdown
  • Check
    Regional growth opportunities
  • Check
    Latest market trends and dynamics
  • Check
    Impact of emerging technologies like AI and automation
  • Check
    Key regulatory updates and ESG considerations

FAQ‘s

vantage logo

Vantage Market Research & Consultancy Services is all about providing accurate and reliable market intelligence to its clients for the seamless execution of their business growth strategies.

© 2025 Vantage Market Research. All right reserved
Secured Bysecured by